ATOMOXETINE HYDROCHLORIDE

ATOMOXETINE HYDROCHLORIDE was reported 23875 times

ATOMOXETINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 73 0.4899
1 SEMENURIA 28 0.4746
2 GROWTH HORMONE-PRODUCING PITUITARY TUMOUR 14 0.4375
3 FIGHT IN SCHOOL 16 0.2162
4 EXCITABILITY 56 0.2051
5 FACET JOINT SYNDROME 545 0.1672
6 HYPOCHOLESTEROLAEMIA 49 0.1388
7 EARLY MORNING AWAKENING 17 0.1339
8 OVERLAP SYNDROME 87 0.1243
9 OPPOSITIONAL DEFIANT DISORDER 49 0.1241
10 GILBERT'S SYNDROME 10 0.1205
11 SWOLLEN JOINT COUNT 25 0.1000
12 BLEPHAROSPASM 626 0.0993
13 PERIPHERAL VENOUS DISEASE 400 0.0978
14 CONDUCT DISORDER 18 0.0874
15 ONYCHOMADESIS 363 0.0864
16 PENILE DISCHARGE 24 0.0860
17 RHEUMATIC FEVER 375 0.0840
18 SCHOOL REFUSAL 14 0.0819
19 BREAST CANCER STAGE III 506 0.0781
20 ATTENTION-SEEKING BEHAVIOUR 12 0.0764
21 TIC 386 0.0707
22 DUODENAL ULCER PERFORATION 521 0.0700
23 C-REACTIVE PROTEIN 63 0.0680
24 URINARY HESITATION 162 0.0678
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 38 0.0677
26 ONYCHOMYCOSIS 297 0.0676
27 LUPUS VULGARIS 80 0.0635
28 PAINFUL EJACULATION 14 0.0619
29 DEEP VEIN THROMBOSIS POSTOPERATIVE 124 0.0619
30 FEELING HOT AND COLD 18 0.0614
31 ADULTERATED PRODUCT 12 0.0600
32 MUSCLE INJURY 495 0.0597
33 PRESCRIBED OVERDOSE 1145 0.0591
34 EDUCATIONAL PROBLEM 97 0.0583
35 NEGATIVISM 43 0.0567
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 399 0.0556
37 LIP DRY 496 0.0546
38 X-RAY ABNORMAL 96 0.0536
39 URINE AMPHETAMINE POSITIVE 17 0.0518
40 INJURY ASPHYXIATION 23 0.0501
41 SHUNT MALFUNCTION 14 0.0495
42 PILOERECTION 54 0.0493
43 GASTRIC HYPOMOTILITY 15 0.0489
44 C-REACTIVE PROTEIN ABNORMAL 313 0.0487
45 FOLLICULITIS 511 0.0487
46 HELICOBACTER INFECTION 499 0.0485
47 TOURETTE'S DISORDER 11 0.0485
48 HYPERCHOLESTEROLAEMIA 461 0.0477
49 DISLOCATION OF VERTEBRA 108 0.0473
50 SCROTAL DISORDER 14 0.0464
51 MERYCISM 13 0.0455
52 REGRESSIVE BEHAVIOUR 13 0.0447
53 PEMPHIGUS 559 0.0447
54 NAIL DISORDER 387 0.0442
55 SWOLLEN JOINT COUNT INCREASED 138 0.0432
56 AMPHETAMINES POSITIVE 32 0.0427
57 STOMACH DISCOMFORT 220 0.0425
58 BURSITIS 515 0.0424
59 INFUSION SITE REACTION 126 0.0421
60 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 87 0.0419
61 BELLIGERENCE 18 0.0419
62 VIRAL DIARRHOEA 14 0.0407
63 TESTICULAR PAIN 128 0.0403
64 STRESS SYMPTOMS 18 0.0400
65 WOUND INFECTION 432 0.0394
66 TRICHOTILLOMANIA 23 0.0392
67 IMPULSIVE BEHAVIOUR 147 0.0391
68 PORPHYRIA ACUTE 56 0.0390
69 MONONUCLEOSIS SYNDROME 10 0.0389
70 HAND DEFORMITY 510 0.0388
71 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 30 0.0382
72 LIVE BIRTH 306 0.0365
73 EJACULATION DISORDER 99 0.0349
74 PERICARDITIS 585 0.0348
75 SOCIAL PHOBIA 12 0.0348
76 ORGASM ABNORMAL 28 0.0346
77 FINGER DEFORMITY 167 0.0344
78 PROSTATIC PAIN 14 0.0343
79 PREMATURE EJACULATION 21 0.0326
80 GRIP STRENGTH DECREASED 286 0.0325
81 BACK INJURY 347 0.0319
82 PSYCHOMOTOR HYPERACTIVITY 520 0.0313
83 SELF INJURIOUS BEHAVIOUR 93 0.0305
84 DISTRACTIBILITY 35 0.0304
85 TESTICULAR DISORDER 30 0.0298
86 SCROTAL PAIN 16 0.0296
87 SYNOVITIS 533 0.0295
88 BONE EROSION 104 0.0294
89 JOINT RANGE OF MOTION DECREASED 394 0.0293
90 FEELING OF RELAXATION 20 0.0292
91 RETINITIS 50 0.0289
92 EYE ROLLING 20 0.0282
93 SHUNT OCCLUSION 14 0.0276
94 OBESITY 432 0.0271
95 BLOOD GROWTH HORMONE INCREASED 15 0.0269
96 DERMATILLOMANIA 16 0.0268
97 DRUG WITHDRAWAL HEADACHE 11 0.0265
98 RAYNAUD'S PHENOMENON 24 0.0256
99 WOLFF-PARKINSON-WHITE SYNDROME 12 0.0254
100 TASTE DISORDER 515 0.0254
101 PRODUCT LABEL CONFUSION 146 0.0250
102 SLEEP WALKING 14 0.0243
103 ABNORMAL BEHAVIOUR 958 0.0242
104 RETROGRADE EJACULATION 19 0.0240
105 HOSTILITY 59 0.0232
106 REPETITIVE SPEECH 13 0.0231
107 EPILEPSY 693 0.0226
108 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 15 0.0225
109 GLOSSODYNIA 492 0.0220
110 GROWTH RETARDATION 64 0.0217
111 IRRITABLE BOWEL SYNDROME 465 0.0217
112 FLAT AFFECT 49 0.0211
113 MALE ORGASMIC DISORDER 11 0.0211
114 HEAD BANGING 12 0.0211
115 COMPULSIONS 14 0.0210
116 ANTISOCIAL BEHAVIOUR 21 0.0210
117 RHEUMATOID FACTOR POSITIVE 119 0.0206
118 FIBROMYALGIA 500 0.0205
119 LIVER INJURY 486 0.0198
120 NORMAL NEWBORN 107 0.0197
121 WOUND 543 0.0194
122 DRUG SCREEN POSITIVE 151 0.0191
123 COELIAC DISEASE 187 0.0190
124 AGGRESSION 947 0.0189
125 CONGENITAL ANOMALY 145 0.0187
126 TYPE 2 DIABETES MELLITUS 610 0.0181
127 HOMICIDAL IDEATION 73 0.0180
128 ANOREXIA 231 0.0179
129 MOOD SWINGS 558 0.0175
130 SERONEGATIVE ARTHRITIS 20 0.0175
131 OBSESSIVE THOUGHTS 31 0.0172
132 ANGER 578 0.0171
133 IMPULSE-CONTROL DISORDER 35 0.0170
134 SELF-INJURIOUS IDEATION 70 0.0167
135 SYSTEMIC LUPUS ERYTHEMATOSUS 590 0.0166
136 AUTOIMMUNE DISORDER 161 0.0165
137 BIPOLAR I DISORDER 36 0.0164
138 URINE FLOW DECREASED 39 0.0163
139 RETCHING 344 0.0161
140 MATERNAL EXPOSURE TIMING UNSPECIFIED 60 0.0160
141 SOCIAL AVOIDANT BEHAVIOUR 90 0.0155
142 MYDRIASIS 198 0.0154
143 IMPAIRED HEALING 497 0.0151
144 ENURESIS 61 0.0151
145 PSORIATIC ARTHROPATHY 609 0.0150
146 C-REACTIVE PROTEIN INCREASED 542 0.0149
147 SOMATIC SYMPTOM DISORDER 16 0.0148
148 PENILE SIZE REDUCED 14 0.0147
149 CLAUSTROPHOBIA 16 0.0147
150 INDIFFERENCE 11 0.0146
151 CRYING 532 0.0146
152 INAPPROPRIATE AFFECT 23 0.0145
153 BREAST CANCER STAGE II 120 0.0144
154 DISTURBANCE IN ATTENTION 765 0.0142
155 CONTRAINDICATED PRODUCT ADMINISTERED 426 0.0141
156 YAWNING 37 0.0139
157 SLEEP TALKING 23 0.0135
158 SCREAMING 86 0.0135
159 TESTICULAR SWELLING 17 0.0134
160 PERSONALITY CHANGE 123 0.0132
161 DRUG SCREEN FALSE POSITIVE 36 0.0130
162 STARING 31 0.0128
163 MORBID THOUGHTS 15 0.0128
164 NIGHT SWEATS 412 0.0128
165 LOGORRHOEA 44 0.0125
166 PHYSICAL ASSAULT 26 0.0124
167 SUICIDAL BEHAVIOUR 51 0.0122
168 MICTURITION DISORDER 42 0.0121
169 INTENTIONAL MISUSE 23 0.0120
170 DRUG TOLERANCE 60 0.0118
171 EXOSTOSIS 108 0.0118
172 VIOLENCE-RELATED SYMPTOM 18 0.0116
173 GAIT INABILITY 387 0.0116
174 INSULIN-LIKE GROWTH FACTOR INCREASED 16 0.0112
175 LOWER RESPIRATORY TRACT INFECTION 509 0.0112
176 BLOOD CHOLESTEROL INCREASED 518 0.0111
177 SUICIDAL IDEATION 1010 0.0110
178 DAYDREAMING 17 0.0110
179 OSTEOARTHRITIS 466 0.0110
180 IRRITABILITY 658 0.0109
181 ADVERSE REACTION 144 0.0108
182 ADJUSTMENT DISORDER 14 0.0108
183 MANIA 177 0.0107
184 SINUS ARRHYTHMIA 14 0.0107
185 PHARYNGOLARYNGEAL PAIN 57 0.0107
186 DRUG TOLERANCE DECREASED 30 0.0107
187 HYPOMANIA 39 0.0106
188 DRY MOUTH 859 0.0106
189 NEGATIVE THOUGHTS 31 0.0106
190 LOWER LIMB FRACTURE 203 0.0106
191 PENIS DISORDER 26 0.0105
192 PUSTULAR PSORIASIS 36 0.0105
193 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 68 0.0105
194 TEARFULNESS 45 0.0105
195 PULSE ABNORMAL 25 0.0104
196 LIBIDO INCREASED 21 0.0103
197 ULCER HAEMORRHAGE 70 0.0103
198 OBSESSIVE-COMPULSIVE DISORDER 83 0.0103
199 SEXUAL DYSFUNCTION 121 0.0103
200 EXCESSIVE EYE BLINKING 15 0.0101
201 MUSCLE CRAMP 18 0.0101
202 PRODUCT TAMPERING 18 0.0100
203 PERSONALITY DISORDER 26 0.0099
204 COMPLEX PARTIAL SEIZURES 11 0.0099
205 CATAPLEXY 14 0.0099
206 ABNORMAL SLEEP-RELATED EVENT 13 0.0098
207 DISTURBANCE IN SOCIAL BEHAVIOUR 23 0.0098
208 ARTHROPATHY 542 0.0097
209 INFLAMMATION 501 0.0097
210 POSTICTAL STATE 10 0.0096
211 LIVER FUNCTION TEST INCREASED 206 0.0096
212 TACHYPHRENIA 33 0.0095
213 FRUSTRATION 34 0.0095
214 RED BLOOD CELL SEDIMENTATION RATE INCREASED 102 0.0092
215 APATHY 134 0.0092
216 INTENTIONAL SELF-INJURY 182 0.0090
217 LUNG DISORDER 440 0.0090
218 AFFECT LABILITY 85 0.0088
219 GRAND MAL CONVULSION 81 0.0088
220 CONVERSION DISORDER 17 0.0088
221 LUPUS-LIKE SYNDROME 79 0.0087
222 EMOTIONAL DISORDER 267 0.0087
223 SLEEP DISORDER 610 0.0086
224 DYSURIA 315 0.0085
225 VISUAL DISTURBANCE 49 0.0085
226 STRABISMUS 25 0.0085
227 PULMONARY FIBROSIS 163 0.0085
228 FEELINGS OF WORTHLESSNESS 11 0.0084
229 BLISTER 473 0.0084
230 WHEEZING 495 0.0083
231 INFUSION RELATED REACTION 552 0.0083
232 HALLUCINATION, AUDITORY 132 0.0083
233 MOTION SICKNESS 16 0.0083
234 HYPERPHAGIA 33 0.0083
235 GASTROOESOPHAGEAL REFLUX DISEASE 665 0.0083
236 THERAPEUTIC PRODUCT EFFECT DECREASED 370 0.0083
237 MOOD ALTERED 225 0.0082
238 PRESCRIBED UNDERDOSE 164 0.0082
239 BREATH ODOUR 20 0.0082
240 INITIAL INSOMNIA 84 0.0082
241 THINKING ABNORMAL 152 0.0081
242 MUSCULOSKELETAL PAIN 427 0.0081
243 ENERGY INCREASED 48 0.0081
244 PARANOIA 140 0.0081
245 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 139 0.0081
246 DRUG-INDUCED LIVER INJURY 253 0.0081
247 HYPERACUSIS 30 0.0081
248 IMPATIENCE 15 0.0080
249 AGITATION 586 0.0080
250 STOMATITIS 483 0.0080
251 TERMINAL INSOMNIA 14 0.0079
252 HEPATIC ENZYME INCREASED 538 0.0079
253 COMMUNICATION DISORDER 30 0.0078
254 DYSPHEMIA 34 0.0077
255 ANORGASMIA 21 0.0077
256 HEPATITIS 197 0.0077
257 FEELING JITTERY 146 0.0077
258 SCIATICA 122 0.0076
259 ELECTROENCEPHALOGRAM ABNORMAL 24 0.0076
260 EYE INJURY 23 0.0076
261 WALKING AID USER 49 0.0074
262 BREAST DISCHARGE 13 0.0074
263 MIGRAINE 705 0.0074
264 ATTENTION DEFICIT HYPERACTIVITY DISORDER 31 0.0074
265 MATERNAL EXPOSURE DURING PREGNANCY 649 0.0073
266 BIPOLAR DISORDER 79 0.0073
267 TONSILLECTOMY 12 0.0072
268 ERECTILE DYSFUNCTION 184 0.0072
269 INFECTIOUS MONONUCLEOSIS 16 0.0071
270 JOINT DESTRUCTION 11 0.0071
271 LAZINESS 12 0.0070
272 EJACULATION FAILURE 14 0.0070
273 PRIAPISM 24 0.0070
274 AFFECTIVE DISORDER 54 0.0069
275 INFREQUENT BOWEL MOVEMENTS 17 0.0068
276 SWELLING 636 0.0068
277 SOMNOLENCE 1361 0.0068
278 BRUXISM 36 0.0067
279 INCREASED APPETITE 127 0.0066
280 MIDDLE INSOMNIA 124 0.0066
281 RASH VESICULAR 32 0.0066
282 EYE MOVEMENT DISORDER 45 0.0066
283 MAJOR DEPRESSION 47 0.0064
284 EAR PAIN 125 0.0064
285 PSYCHOTIC DISORDER 189 0.0064
286 NARCOLEPSY 12 0.0064
287 EMOTIONAL POVERTY 11 0.0063
288 PROSTATITIS 19 0.0062
289 UNDERWEIGHT 12 0.0061
290 HYPERREFLEXIA 21 0.0060
291 PERIPHERAL COLDNESS 82 0.0060
292 HOMICIDE 11 0.0060
293 INTENTIONAL PRODUCT USE ISSUE 521 0.0059
294 ILL-DEFINED DISORDER 355 0.0058
295 SELF ESTEEM DECREASED 14 0.0058
296 SPONDYLITIS 21 0.0058
297 HEPATIC CIRRHOSIS 108 0.0057
298 TENSION 35 0.0057
299 ABDOMINAL PAIN UPPER 1181 0.0057
300 DYSPEPSIA 560 0.0057
301 MEMORY IMPAIRMENT 779 0.0057
302 DRUG INTOLERANCE 544 0.0056
303 DRUG EFFECT DECREASED 303 0.0056
304 PALLOR 153 0.0056
305 PRE-EXISTING CONDITION IMPROVED 35 0.0056
306 JAW FRACTURE 12 0.0056
307 TREATMENT FAILURE 457 0.0055
308 PETIT MAL EPILEPSY 28 0.0055
309 NERVOUSNESS 286 0.0055
310 ALCOHOL USE 20 0.0054
311 RHEUMATOID ARTHRITIS 614 0.0054
312 DEPRESSED MOOD 284 0.0054
313 URINE ANALYSIS ABNORMAL 16 0.0053
314 DEPRESSION 1198 0.0053
315 NIGHTMARE 181 0.0052
316 ABNORMAL DREAMS 144 0.0052
317 DEPRESSION SUICIDAL 18 0.0052
318 BREAST ENLARGEMENT 17 0.0052
319 HYPERVENTILATION 30 0.0052
320 MICTURITION URGENCY 59 0.0052
321 NECK PAIN 288 0.0051
322 PANIC REACTION 37 0.0051
323 URINARY RETENTION 171 0.0051
324 HANGOVER 18 0.0051
325 MOBILITY DECREASED 367 0.0051
326 DEPRESSIVE SYMPTOM 18 0.0051
327 HYPOAESTHESIA 763 0.0051
328 ROAD TRAFFIC ACCIDENT 213 0.0051
329 EXPOSURE DURING PREGNANCY 315 0.0051
330 INJURY 354 0.0050
331 SUICIDE ATTEMPT 304 0.0050
332 HALLUCINATIONS, MIXED 21 0.0050
333 HEART RATE INCREASED 494 0.0050
334 CONFUSIONAL STATE 805 0.0050
335 FEELING ABNORMAL 1186 0.0049
336 PARAESTHESIA 778 0.0049
337 MEDICATION ERROR 274 0.0049
338 PANIC DISORDER 19 0.0049
339 BRADYPHRENIA 32 0.0049
340 CHANGE OF BOWEL HABIT 10 0.0049
341 INSOMNIA 1281 0.0048
342 MIGRAINE WITH AURA 13 0.0048
343 SLEEP TERROR 20 0.0047
344 FORMICATION 33 0.0047
345 COLD SWEAT 83 0.0047
346 DEREALISATION 10 0.0046
347 RESTLESSNESS 169 0.0046
348 PENILE PAIN 14 0.0046
349 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 78 0.0046
350 DISCOMFORT 280 0.0046
351 EUPHORIC MOOD 47 0.0046
352 FEELING DRUNK 34 0.0046
353 LISTLESS 15 0.0045
354 HYPERSOMNIA 129 0.0045
355 THIRST 80 0.0045
356 HEPATOCELLULAR DAMAGE 10 0.0044
357 SUSPECTED OFF LABEL USE 20 0.0044
358 FOOT DEFORMITY 49 0.0044
359 MUSCLE TWITCHING 101 0.0044
360 READING DISORDER 10 0.0044
361 NEUROLOGICAL SYMPTOM 25 0.0044
362 GENERAL PHYSICAL HEALTH DETERIORATION 503 0.0043
363 DECREASED APPETITE 1001 0.0043
364 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 304 0.0043
365 BLOOD ALKALINE PHOSPHATASE INCREASED 106 0.0043
366 CONVULSION 244 0.0043
367 ABDOMINAL DISCOMFORT 715 0.0043
368 BLOOD PROLACTIN INCREASED 20 0.0042
369 DECREASED INTEREST 25 0.0042
370 MYOSITIS 38 0.0042
371 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
372 URINARY TRACT DISORDER 19 0.0042
373 BRAIN INJURY 42 0.0042
374 LEARNING DISORDER 10 0.0041
375 LETHARGY 237 0.0041
376 WEIGHT INCREASED 922 0.0041
377 JOINT STIFFNESS 107 0.0041
378 HUNGER 56 0.0040
379 FEAR 108 0.0040
380 INJECTION SITE REACTION 276 0.0040
381 ASPARTATE AMINOTRANSFERASE INCREASED 212 0.0040
382 GASTROINTESTINAL DISORDER 356 0.0040
383 LOSS OF EMPLOYMENT 12 0.0040
384 SLUGGISHNESS 40 0.0039
385 FEELING OF DESPAIR 18 0.0039
386 POLYDIPSIA 15 0.0038
387 SEDATION 99 0.0038
388 PANIC ATTACK 137 0.0038
389 FAECAL INCONTINENCE 18 0.0037
390 HYPERHIDROSIS 482 0.0037
391 GALACTORRHOEA 24 0.0037
392 ANXIETY 1056 0.0037
393 TACHYCARDIA 329 0.0037
394 BLOOD BILIRUBIN INCREASED 100 0.0037
395 BLOOD PRESSURE DIASTOLIC INCREASED 17 0.0037
396 JOINT SWELLING 444 0.0037
397 PSYCHIATRIC SYMPTOM 27 0.0037
398 SOMNAMBULISM 24 0.0037
399 ALANINE AMINOTRANSFERASE INCREASED 224 0.0036
400 HALLUCINATION, VISUAL 77 0.0036
401 HIP ARTHROPLASTY 55 0.0036
402 URTICARIA 599 0.0036
403 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
404 CHROMATURIA 80 0.0035
405 EAR INFECTION 94 0.0035
406 FEELING HOT 215 0.0035
407 CYANOSIS 55 0.0035
408 ABNORMAL SENSATION IN EYE 15 0.0035
409 INFUSION SITE PRURITUS 11 0.0035
410 URINARY INCONTINENCE 103 0.0035
411 GENERAL SYMPTOM 26 0.0035
412 VENTRICULAR EXTRASYSTOLES 36 0.0035
413 HYPERTENSION 731 0.0034
414 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
415 DYSTONIA 66 0.0034
416 ALOPECIA 663 0.0034
417 DELIRIUM 117 0.0034
418 ELECTROCARDIOGRAM QT PROLONGED 121 0.0034
419 PRODUCT QUALITY ISSUE 456 0.0034
420 NASOPHARYNGITIS 617 0.0033
421 DYSGRAPHIA 22 0.0033
422 DROOLING 23 0.0033
423 EXPOSURE DURING BREAST FEEDING 11 0.0033
424 OEDEMA 180 0.0033
425 MUSCLE SPASMS 608 0.0033
426 JOINT DISLOCATION 35 0.0033
427 GROIN PAIN 29 0.0033
428 ANXIETY DISORDER 11 0.0033
429 POST-TRAUMATIC STRESS DISORDER 22 0.0033
430 AUTISM SPECTRUM DISORDER 18 0.0033
431 ABDOMINAL DISTENSION 341 0.0033
432 DISSOCIATION 25 0.0033
433 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
434 VOMITING 1522 0.0032
435 PHARYNGITIS STREPTOCOCCAL 35 0.0032
436 OCULAR ICTERUS 14 0.0032
437 CONTUSION 308 0.0032
438 DIFFICULTY IN WALKING 11 0.0032
439 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
440 SNORING 12 0.0032
441 DYSPHORIA 16 0.0032
442 RESPIRATORY DISORDER 94 0.0031
443 GYNAECOMASTIA 97 0.0031
444 MUSCULOSKELETAL STIFFNESS 273 0.0031
445 DYSKINESIA 126 0.0031
446 SINUS TACHYCARDIA 44 0.0031
447 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
448 EATING DISORDER 65 0.0030
449 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
450 FOOD CRAVING 16 0.0030
451 ALCOHOLISM 13 0.0030
452 DELUSION 47 0.0030
453 CHEST PAIN 560 0.0030
454 APPETITE DISORDER 20 0.0030
455 AMNESIA 196 0.0030
456 FEELING COLD 83 0.0030
457 POTENTIATING DRUG INTERACTION 10 0.0030
458 PERIPHERAL SWELLING 459 0.0030
459 JAUNDICE 80 0.0030
460 EXERCISE TOLERANCE DECREASED 17 0.0030
461 UNDERDOSE 214 0.0029
462 ACCIDENTAL OVERDOSE 107 0.0029
463 TRISMUS 15 0.0029
464 FEELING OF BODY TEMPERATURE CHANGE 17 0.0029
465 URINE ODOUR ABNORMAL 17 0.0029
466 APPENDICITIS 27 0.0029
467 SLEEP APNOEA SYNDROME 55 0.0029
468 CHOKING 56 0.0029
469 ERECTION INCREASED 12 0.0029
470 DIZZINESS 1430 0.0029
471 CHOLECYSTITIS CHRONIC 19 0.0028
472 THERAPY NON-RESPONDER 127 0.0028
473 PALPITATIONS 330 0.0028
474 OVERWEIGHT 15 0.0028
475 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
476 POLLAKIURIA 115 0.0028
477 MUSCULAR WEAKNESS 313 0.0028
478 FOREIGN BODY 11 0.0027
479 SKIN PAPILLOMA 11 0.0027
480 FRUSTRATION TOLERANCE DECREASED 22 0.0027
481 WEIGHT DECREASED 753 0.0027
482 ERUCTATION 52 0.0027
483 DIZZINESS POSTURAL 26 0.0027
484 DISABILITY 53 0.0027
485 SELF-MEDICATION 11 0.0027
486 TYPE 1 DIABETES MELLITUS 16 0.0027
487 ORTHOSTATIC HYPOTENSION 46 0.0026
488 DYSMENORRHOEA 35 0.0026
489 URINE ABNORMALITY 12 0.0026
490 LIVER DISORDER 117 0.0026
491 BLOOD TESTOSTERONE DECREASED 18 0.0026
492 INCOHERENT 17 0.0026
493 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 126 0.0026
494 HEPATIC ENZYME ABNORMAL 13 0.0026
495 BEHAVIOUR DISORDER 14 0.0026
496 VIRAL INFECTION 86 0.0026
497 ADVERSE EVENT 238 0.0026
498 SENSATION OF HEAVINESS 10 0.0026
499 YELLOW SKIN 12 0.0026
500 PANCREATITIS 135 0.0026
501 CONDITION AGGRAVATED 765 0.0025
502 PULMONARY FUNCTION TEST DECREASED 11 0.0025
503 TONGUE DISORDER 18 0.0025
504 FATIGUE 1931 0.0025
505 LIVER FUNCTION TEST ABNORMAL 72 0.0025
506 SCHIZOPHRENIA 30 0.0025
507 HYPERPROLACTINAEMIA 16 0.0025
508 LOSS OF CONSCIOUSNESS 316 0.0025
509 ASPIRATION 27 0.0025
510 PREGNANCY 49 0.0024
511 LOSS OF LIBIDO 22 0.0024
512 EXTRASYSTOLES 17 0.0024
513 HALLUCINATION 183 0.0024
514 AKATHISIA 33 0.0024
515 HEADACHE 1510 0.0024
516 NAUSEA 1898 0.0024
517 DYSPHAGIA 227 0.0024
518 TREMOR 390 0.0023
519 POOR PERIPHERAL CIRCULATION 10 0.0023
520 PROTHROMBIN TIME PROLONGED 14 0.0023
521 FOOD ALLERGY 18 0.0023
522 KNEE ARTHROPLASTY 49 0.0023
523 GASTROENTERITIS VIRAL 42 0.0023
524 DECREASED ACTIVITY 25 0.0023
525 INCORRECT PRODUCT ADMINISTRATION DURATION 50 0.0023
526 PRODUCT USE IN UNAPPROVED INDICATION 569 0.0023
527 WEIGHT FLUCTUATION 24 0.0023
528 CATATONIA 12 0.0023
529 HYPERSENSITIVITY 424 0.0023
530 POLYARTHRITIS 12 0.0023
531 PRODUCT USE ISSUE 425 0.0023
532 SYNCOPE 224 0.0022
533 FREQUENT BOWEL MOVEMENTS 60 0.0022
534 PAPILLOEDEMA 10 0.0022
535 ABDOMINAL PAIN 515 0.0022
536 ASTHENIA 830 0.0022
537 SINUSITIS 226 0.0022
538 INCONTINENCE 23 0.0022
539 MUSCLE RIGIDITY 26 0.0022
540 HEART RATE IRREGULAR 49 0.0022
541 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
542 HYPERTENSIVE CRISIS 24 0.0022
543 SPEECH DISORDER 112 0.0021
544 BODY TEMPERATURE DECREASED 21 0.0021
545 PHOTOPHOBIA 40 0.0021
546 DERMATITIS CONTACT 24 0.0021
547 DRUG DISPENSING ERROR 32 0.0021
548 POOR QUALITY SLEEP 45 0.0021
549 SEROTONIN SYNDROME 40 0.0021
550 NASAL DRYNESS 13 0.0021
551 DISORIENTATION 82 0.0021
552 DRUG INTERACTION 328 0.0021
553 CONCUSSION 16 0.0021
554 ABNORMAL LOSS OF WEIGHT 14 0.0021
555 MENSTRUAL DISORDER 17 0.0021
556 HORMONE LEVEL ABNORMAL 10 0.0020
557 INTENTIONAL OVERDOSE 131 0.0020
558 HEPATIC STEATOSIS 38 0.0020
559 EPISTAXIS 151 0.0020
560 MULTIPLE DRUG OVERDOSE 10 0.0020
561 HYPERTRANSAMINASAEMIA 14 0.0020
562 TINNITUS 92 0.0020
563 ASTHENOPIA 11 0.0020
564 PROSTATIC DISORDER 11 0.0020
565 PAROSMIA 15 0.0020
566 BLOOD PRESSURE INCREASED 303 0.0020
567 WITHDRAWAL SYNDROME 83 0.0020
568 INTRACRANIAL PRESSURE INCREASED 11 0.0020
569 ASTHMA 223 0.0020
570 CARDIAC MURMUR 17 0.0020
571 ARRHYTHMIA 93 0.0020
572 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0020
573 URINE OUTPUT DECREASED 17 0.0019
574 MENTAL IMPAIRMENT 47 0.0019
575 RESTLESS LEGS SYNDROME 35 0.0019
576 ECONOMIC PROBLEM 29 0.0019
577 SENSATION OF FOREIGN BODY 16 0.0019
578 HOT FLUSH 142 0.0019
579 AMENORRHOEA 33 0.0019
580 COORDINATION ABNORMAL 26 0.0019
581 BODY TEMPERATURE INCREASED 38 0.0019
582 MENTAL DISORDER 81 0.0019
583 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
584 CARDIAC FLUTTER 12 0.0019
585 DRUG INEFFECTIVE 2439 0.0018
586 ADVERSE DRUG REACTION 166 0.0018
587 VITAMIN D DEFICIENCY 18 0.0018
588 BACK DISORDER 30 0.0018
589 RASH 804 0.0018
590 DYSGEUSIA 137 0.0018
591 SKIN DISCOLOURATION 84 0.0018
592 TREATMENT NONCOMPLIANCE 100 0.0018
593 INTENTIONAL PRODUCT MISUSE 160 0.0018
594 THROAT IRRITATION 82 0.0018
595 FAECALOMA 10 0.0018
596 BLADDER DISORDER 18 0.0018
597 NOCTURIA 22 0.0018
598 SALIVARY HYPERSECRETION 18 0.0018
599 OSTEOPOROSIS 74 0.0018
600 HEART RATE ABNORMAL 10 0.0018
601 DRUG TOXICITY 24 0.0018
602 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
603 FOETAL EXPOSURE DURING PREGNANCY 143 0.0018
604 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
605 MYOCARDITIS 20 0.0017
606 CONSTIPATION 378 0.0017
607 LABORATORY TEST ABNORMAL 51 0.0017
608 NO THERAPEUTIC RESPONSE 21 0.0017
609 METABOLIC DISORDER 10 0.0017
610 HYPOTONIA 17 0.0017
611 SINUS HEADACHE 10 0.0017
612 SENSORY DISTURBANCE 27 0.0017
613 OVERDOSE 362 0.0017
614 MYOCLONUS 20 0.0017
615 VISION BLURRED 224 0.0016
616 WHITE BLOOD CELL COUNT INCREASED 62 0.0016
617 MUSCLE TIGHTNESS 26 0.0016
618 SUBSTANCE ABUSE 13 0.0016
619 TARDIVE DYSKINESIA 45 0.0016
620 INFUSION SITE SWELLING 10 0.0016
621 DYSARTHRIA 59 0.0016
622 THERAPEUTIC RESPONSE DECREASED 95 0.0016
623 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
624 MULTIPLE ALLERGIES 12 0.0015
625 EMOTIONAL DISTRESS 185 0.0015
626 MENORRHAGIA 30 0.0015
627 CHILLS 179 0.0015
628 NEUROLEPTIC MALIGNANT SYNDROME 18 0.0015
629 HYPOKINESIA 22 0.0015
630 VENTRICULAR TACHYCARDIA 25 0.0015
631 PAIN 929 0.0015
632 IMPAIRED DRIVING ABILITY 17 0.0015
633 DRUG WITHDRAWAL SYNDROME 131 0.0015
634 SENSORY LOSS 12 0.0015
635 OFF LABEL USE 1304 0.0015
636 LACERATION 14 0.0015
637 HEAD INJURY 47 0.0015
638 MALAISE 647 0.0015
639 INFUSION SITE PAIN 19 0.0015
640 RASH PAPULAR 33 0.0015
641 POLYURIA 12 0.0015
642 ARTHRALGIA 609 0.0015
643 HYPOAESTHESIA ORAL 22 0.0015
644 CROHN'S DISEASE 10 0.0015
645 IMPAIRED WORK ABILITY 31 0.0014
646 ORAL DISCOMFORT 20 0.0014
647 INTENTIONAL DRUG MISUSE 30 0.0014
648 HEPATOMEGALY 14 0.0014
649 THERAPY CHANGE 14 0.0014
650 HEAD DISCOMFORT 25 0.0014
651 HAND FRACTURE 10 0.0014
652 BRAIN FOG 22 0.0014
653 DRUG ADMINISTRATION ERROR 43 0.0014
654 ADRENAL INSUFFICIENCY 17 0.0014
655 DYSPNOEA 791 0.0014
656 INFLUENZA LIKE ILLNESS 115 0.0014
657 BRONCHITIS 103 0.0014
658 NASAL DISCOMFORT 11 0.0014
659 UPPER RESPIRATORY TRACT INFECTION 64 0.0014
660 SEIZURE 159 0.0014
661 DRUG LEVEL DECREASED 14 0.0014
662 RECTAL HAEMORRHAGE 59 0.0014
663 HYPOPHAGIA 35 0.0014
664 TEMPERATURE INTOLERANCE 14 0.0014
665 HYPERBILIRUBINAEMIA 14 0.0014
666 COGNITIVE DISORDER 63 0.0013
667 SINUS DISORDER 26 0.0013
668 INFUSION SITE ERYTHEMA 11 0.0013
669 BLOOD PRESSURE DECREASED 86 0.0013
670 SNEEZING 29 0.0013
671 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
672 INFECTION 187 0.0013
673 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
674 EYE DISORDER 42 0.0013
675 GASTROINTESTINAL PAIN 14 0.0013
676 COMPLETED SUICIDE 106 0.0013
677 WRONG TECHNIQUE IN DRUG USAGE PROCESS 46 0.0013
678 NASAL CONGESTION 74 0.0013
679 PRODUCT TASTE ABNORMAL 17 0.0013
680 INTRAOCULAR PRESSURE INCREASED 16 0.0013
681 DRUG PRESCRIBING ERROR 24 0.0012
682 FALL 415 0.0012
683 HYPERTHYROIDISM 18 0.0012
684 INSURANCE ISSUE 19 0.0012
685 RESPIRATORY RATE INCREASED 11 0.0012
686 DEPRESSED LEVEL OF CONSCIOUSNESS 49 0.0012
687 PRESYNCOPE 30 0.0012
688 SCRATCH 13 0.0012
689 DECREASED IMMUNE RESPONSIVENESS 12 0.0012
690 OEDEMA PERIPHERAL 149 0.0012
691 ABNORMAL FAECES 10 0.0012
692 DEVELOPMENTAL DELAY 11 0.0012
693 PAIN IN EXTREMITY 358 0.0012
694 IMMUNE SYSTEM DISORDER 16 0.0012
695 VASCULITIS 14 0.0012
696 SEASONAL ALLERGY 17 0.0012
697 INCREASED TENDENCY TO BRUISE 11 0.0012
698 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
699 APHASIA 36 0.0012
700 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
701 OSTEOPENIA 18 0.0012
702 ANHEDONIA 31 0.0012
703 EAR DISCOMFORT 12 0.0012
704 EXTRAPYRAMIDAL DISORDER 29 0.0012
705 PYREXIA 403 0.0012
706 THERAPEUTIC RESPONSE UNEXPECTED 52 0.0012
707 MENSTRUATION IRREGULAR 31 0.0012
708 MOVEMENT DISORDER 37 0.0012
709 PETECHIAE 12 0.0011
710 MITRAL VALVE INCOMPETENCE 13 0.0011
711 BLOOD CREATINE PHOSPHOKINASE INCREASED 33 0.0011
712 INFLUENZA 126 0.0011
713 PHARYNGITIS 14 0.0011
714 HEPATOTOXICITY 25 0.0011
715 GAIT DISTURBANCE 211 0.0011
716 RHINORRHOEA 71 0.0011
717 OESOPHAGITIS 12 0.0011
718 GASTROENTERITIS 16 0.0011
719 DYSSTASIA 32 0.0011
720 ATAXIA 13 0.0011
721 GLAUCOMA 21 0.0011
722 RASH PRURITIC 59 0.0011
723 HYPERLIPIDAEMIA 13 0.0011
724 DIARRHOEA 702 0.0011
725 HYPOTHERMIA 11 0.0011
726 CHEST DISCOMFORT 111 0.0011
727 DRY THROAT 11 0.0011
728 HEART RATE DECREASED 38 0.0011
729 ANGINA PECTORIS 31 0.0011
730 PLATELET COUNT INCREASED 14 0.0011
731 IMMUNODEFICIENCY 16 0.0011
732 PNEUMONIA 347 0.0011
733 GALLBLADDER DISORDER 19 0.0011
734 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
735 SWELLING FACE 69 0.0011
736 RASH MACULAR 37 0.0011
737 CARDIOMEGALY 13 0.0011
738 FLUSHING 107 0.0011
739 ABNORMAL WEIGHT GAIN 13 0.0011
740 CHOLECYSTECTOMY 12 0.0010
741 PARAESTHESIA ORAL 15 0.0010
742 RENAL PAIN 11 0.0010
743 PHOTOSENSITIVITY REACTION 17 0.0010
744 ACNE 78 0.0010
745 DRUG LEVEL INCREASED 17 0.0010
746 EXPIRED PRODUCT ADMINISTERED 34 0.0010
747 KIDNEY INFECTION 20 0.0010
748 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 206 0.0010
749 SKIN LACERATION 11 0.0010
750 DRUG DOSE OMISSION 167 0.0010
751 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
752 FLATULENCE 57 0.0010
753 FOOT FRACTURE 19 0.0010
754 DENTAL CARIES 11 0.0010
755 LACRIMATION INCREASED 30 0.0010
756 VENTRICULAR FIBRILLATION 11 0.0010
757 PRODUCT SUBSTITUTION ISSUE 57 0.0010
758 NEPHROLITHIASIS 45 0.0010
759 PRURITUS 371 0.0010
760 COLITIS ULCERATIVE 43 0.0010
761 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
762 STEVENS-JOHNSON SYNDROME 21 0.0009
763 RESPIRATORY TRACT CONGESTION 15 0.0009
764 EYE PAIN 53 0.0009
765 JOINT INJURY 20 0.0009
766 GASTRIC DISORDER 32 0.0009
767 UNRESPONSIVE TO STIMULI 24 0.0009
768 HEPATIC FAILURE 28 0.0009
769 THROAT TIGHTNESS 25 0.0009
770 GASTRITIS 24 0.0009
771 INTENTIONAL DOSE OMISSION 26 0.0009
772 BLOOD URINE PRESENT 17 0.0009
773 NEEDLE ISSUE 26 0.0009
774 DIPLOPIA 23 0.0009
775 RESPIRATORY TRACT INFECTION 23 0.0009
776 CARDIOMYOPATHY 13 0.0009
777 PRODUCT AVAILABILITY ISSUE 20 0.0009
778 LYMPHADENOPATHY 31 0.0009
779 OROPHARYNGEAL PAIN 81 0.0009
780 HAEMORRHOIDS 17 0.0009
781 SURGERY 51 0.0009
782 HAEMATEMESIS 22 0.0009
783 DIABETES MELLITUS 66 0.0009
784 VISUAL IMPAIRMENT 107 0.0009
785 HOSPITALISATION 132 0.0009
786 UPPER LIMB FRACTURE 17 0.0009
787 VERTIGO 52 0.0009
788 PHARMACEUTICAL PRODUCT COMPLAINT 22 0.0008
789 HYPOGLYCAEMIA 41 0.0008
790 NO ADVERSE EVENT 153 0.0008
791 THERAPEUTIC RESPONSE SHORTENED 28 0.0008
792 LEUKOPENIA 42 0.0008
793 ACCIDENT 10 0.0008
794 EYE SWELLING 31 0.0008
795 NERVOUS SYSTEM DISORDER 26 0.0008
796 DRUG EXPOSURE DURING PREGNANCY 28 0.0008
797 METRORRHAGIA 14 0.0008
798 MUSCULOSKELETAL DISCOMFORT 14 0.0008
799 BLOOD PRESSURE ABNORMAL 16 0.0008
800 SWOLLEN TONGUE 25 0.0008
801 PRODUCT PHYSICAL ISSUE 16 0.0008
802 CHOLELITHIASIS 26 0.0008
803 DIABETIC KETOACIDOSIS 19 0.0008
804 GASTRIC ULCER 15 0.0008
805 COUGH 221 0.0008
806 ANKLE FRACTURE 12 0.0008
807 TOOTHACHE 14 0.0008
808 BLOOD GLUCOSE DECREASED 37 0.0008
809 PARALYSIS 11 0.0008
810 HYPERGLYCAEMIA 28 0.0008
811 CIRCULATORY COLLAPSE 13 0.0008
812 VISUAL ACUITY REDUCED 25 0.0008
813 ABSCESS 12 0.0008
814 ECZEMA 39 0.0007
815 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
816 SINUS CONGESTION 10 0.0007
817 FEEDING DISORDER 15 0.0007
818 LYMPHOCYTE COUNT DECREASED 13 0.0007
819 IMPAIRED GASTRIC EMPTYING 10 0.0007
820 OXYGEN SATURATION DECREASED 41 0.0007
821 FLUID RETENTION 37 0.0007
822 UNEVALUABLE EVENT 55 0.0007
823 MENTAL STATUS CHANGES 20 0.0007
824 MYALGIA 122 0.0007
825 PRODUCT PRESCRIBING ERROR 17 0.0007
826 SCAR 12 0.0007
827 LIMB INJURY 19 0.0007
828 PRODUCT USE COMPLAINT 11 0.0007
829 PNEUMOTHORAX 11 0.0007
830 CYSTITIS 22 0.0007
831 ILLNESS 71 0.0007
832 HYPOTHYROIDISM 22 0.0007
833 HAEMATOCHEZIA 38 0.0007
834 FRACTURE 13 0.0007
835 HYPOTENSION 137 0.0007
836 ERYTHEMA 140 0.0007
837 ABDOMINAL PAIN LOWER 17 0.0007
838 DEHYDRATION 89 0.0007
839 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
840 FACE OEDEMA 11 0.0007
841 COMA 31 0.0007
842 PHARYNGEAL OEDEMA 10 0.0006
843 ABORTION SPONTANEOUS 26 0.0006
844 ARTHRITIS 51 0.0006
845 ABASIA 16 0.0006
846 PRURITUS GENERALISED 14 0.0006
847 MUSCULOSKELETAL CHEST PAIN 10 0.0006
848 EJECTION FRACTION DECREASED 10 0.0006
849 BURNING SENSATION 45 0.0006
850 PAIN IN JAW 18 0.0006
851 SKIN DISORDER 21 0.0006
852 DERMATITIS ATOPIC 33 0.0006
853 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
854 HAEMATURIA 21 0.0006
855 BALANCE DISORDER 53 0.0006
856 APPLICATION SITE ERYTHEMA 16 0.0006
857 MULTIPLE FRACTURES 10 0.0006
858 STAPHYLOCOCCAL INFECTION 20 0.0006
859 DYSPHONIA 35 0.0006
860 BACK PAIN 138 0.0006
861 HEMIPARESIS 10 0.0006
862 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
863 TOOTH DISORDER 13 0.0006
864 FUNGAL INFECTION 19 0.0006
865 MOUTH ULCERATION 12 0.0006
866 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
867 RASH ERYTHEMATOUS 27 0.0006
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 100 0.0006
869 HAEMATOCRIT DECREASED 11 0.0006
870 LIMB DISCOMFORT 17 0.0005
871 SKIN LESION 15 0.0005
872 NEOPLASM PROGRESSION 19 0.0005
873 PRODUCTIVE COUGH 26 0.0005
874 RESPIRATORY ARREST 15 0.0005
875 ACUTE MYOCARDIAL INFARCTION 16 0.0005
876 BLOOD PRESSURE FLUCTUATION 13 0.0005
877 TRANSAMINASES INCREASED 12 0.0005
878 CONJUNCTIVITIS 10 0.0005
879 BLOOD POTASSIUM DECREASED 16 0.0005
880 BLOOD SODIUM DECREASED 10 0.0005
881 VAGINAL HAEMORRHAGE 23 0.0005
882 PSORIASIS 69 0.0005
883 DRY EYE 26 0.0005
884 PERICARDIAL EFFUSION 12 0.0005
885 WHITE BLOOD CELL COUNT DECREASED 56 0.0005
886 URINARY TRACT INFECTION 85 0.0005
887 HYPOKALAEMIA 23 0.0005
888 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
889 DRUG EFFECT INCOMPLETE 18 0.0005
890 NEURALGIA 12 0.0005
891 DEEP VEIN THROMBOSIS 32 0.0005
892 ORAL PAIN 11 0.0005
893 ENCEPHALOPATHY 12 0.0005
894 OCULAR HYPERAEMIA 23 0.0005
895 HEPATIC FUNCTION ABNORMAL 18 0.0005
896 EYE PRURITUS 16 0.0005
897 ATRIAL FIBRILLATION 45 0.0005
898 FAECES DISCOLOURED 10 0.0005
899 DEAFNESS 12 0.0005
900 PRODUCT DOSE OMISSION ISSUE 134 0.0005
901 ANAPHYLACTIC REACTION 25 0.0005
902 PULMONARY EMBOLISM 43 0.0005
903 EXTRA DOSE ADMINISTERED 18 0.0004
904 INCORRECT DOSE ADMINISTERED 101 0.0004
905 CARDIAC DISORDER 41 0.0004
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
907 CARDIOVASCULAR DISORDER 11 0.0004
908 TOXICITY TO VARIOUS AGENTS 73 0.0004
909 HAEMOPTYSIS 12 0.0004
910 RASH GENERALISED 11 0.0004
911 CARDIAC ARREST 35 0.0004
912 INJECTION SITE HAEMORRHAGE 33 0.0004
913 DYSPNOEA EXERTIONAL 15 0.0004
914 INTESTINAL OBSTRUCTION 15 0.0004
915 DRY SKIN 53 0.0004
916 CELLULITIS 20 0.0004
917 CHRONIC KIDNEY DISEASE 30 0.0004
918 COVID-19 69 0.0004
919 BLINDNESS 16 0.0004
920 CEREBRAL HAEMORRHAGE 14 0.0004
921 BLOOD GLUCOSE INCREASED 73 0.0004
922 BLOOD CREATININE INCREASED 25 0.0004
923 EYE IRRITATION 22 0.0004
924 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27 0.0004
925 INJECTION SITE MASS 14 0.0004
926 HYPOACUSIS 16 0.0004
927 PLATELET COUNT DECREASED 39 0.0004
928 INJECTION SITE SWELLING 28 0.0004
929 PRODUCT ADHESION ISSUE 13 0.0004
930 PROCEDURAL PAIN 10 0.0004
931 LIP SWELLING 12 0.0004
932 CARDIO-RESPIRATORY ARREST 15 0.0004
933 INJECTION SITE RASH 11 0.0004
934 DISEASE RECURRENCE 17 0.0004
935 DEVICE MALFUNCTION 25 0.0004
936 SKIN EXFOLIATION 30 0.0004
937 BONE DENSITY DECREASED 11 0.0004
938 PLEURAL EFFUSION 21 0.0003
939 PRODUCT DOSE OMISSION 22 0.0003
940 CARDIAC FAILURE 27 0.0003
941 DRUG DEPENDENCE 54 0.0003
942 INCORRECT ROUTE OF DRUG ADMINISTRATION 12 0.0003
943 HAEMORRHAGE 35 0.0003
944 PREMATURE BABY 10 0.0003
945 CORONARY ARTERY DISEASE 10 0.0003
946 BONE PAIN 19 0.0003
947 RENAL DISORDER 15 0.0003
948 RHABDOMYOLYSIS 13 0.0003
949 INJECTION SITE PAIN 95 0.0003
950 DEVICE EXPULSION 20 0.0003
951 NEUTROPENIA 41 0.0003
952 CEREBROVASCULAR ACCIDENT 50 0.0003
953 ANGIOEDEMA 13 0.0003
954 DEPENDENCE 16 0.0003
955 DRUG ABUSE 24 0.0003
956 INJECTION SITE PRURITUS 19 0.0003
957 BRADYCARDIA 15 0.0003
958 HAEMOGLOBIN DECREASED 29 0.0003
959 NEUROPATHY PERIPHERAL 26 0.0003
960 THERAPY CESSATION 14 0.0003
961 NEUTROPHIL COUNT DECREASED 11 0.0003
962 MYOCARDIAL INFARCTION 47 0.0003
963 SKIN BURNING SENSATION 19 0.0003
964 RENAL FAILURE 35 0.0003
965 HERPES ZOSTER 15 0.0003
966 MULTIPLE SCLEROSIS 12 0.0003
967 THROMBOCYTOPENIA 28 0.0003
968 DEVICE BREAKAGE 10 0.0002
969 ANAEMIA 45 0.0002
970 DEVICE LEAKAGE 10 0.0002
971 RENAL IMPAIRMENT 19 0.0002
972 THROMBOSIS 18 0.0002
973 RESPIRATORY FAILURE 16 0.0002
974 HYPONATRAEMIA 12 0.0002
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
976 INJECTION SITE ERYTHEMA 26 0.0002
977 DEVICE ISSUE 18 0.0002
978 INJECTION SITE BRUISING 16 0.0002
979 BREAST CANCER 18 0.0002
980 THERAPY INTERRUPTED 13 0.0002
981 SEPSIS 20 0.0002
982 DEATH 150 0.0002
983 CATARACT 10 0.0002
984 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
985 DRUG DOSE OMISSION BY DEVICE 12 0.0002
986 FEBRILE NEUTROPENIA 10 0.0002
987 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
988 ACUTE KIDNEY INJURY 22 0.0001
989 PRODUCT STORAGE ERROR 10 0.0001
990 DISEASE PROGRESSION 10 0.0001